LCAM
COYA icon

Long Corridor Asset Management’s Coya Therapeutics COYA Stock Holding History

Long Corridor Asset Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$153K Hold
38,766
– – 0.04% 38
2025
Q4 		$225K Buy
+38,766
New +$236K 0.01% 20

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Long Corridor Asset Management's COYA Position: Q1 2026 in Review

Long Corridor Asset Management held its Coya Therapeutics (COYA) position steady in Q1 2026 at 38,766 shares worth $153K. The position accounts for 0.04% of the portfolio, ranked #38.

Long Corridor Asset Management first reported a position in COYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $225K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Long Corridor Asset Management held 38,766 shares of Coya Therapeutics worth $153K as of Q1 2026.
  • Long Corridor Asset Management left its Coya Therapeutics share count unchanged in Q1 2026.
  • Coya Therapeutics made up 0.04% of Long Corridor Asset Management's portfolio in Q1 2026, its #38 holding.
  • Long Corridor Asset Management first reported a position in Coya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Long Corridor Asset Management's Coya Therapeutics position peaked at $225K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Long Corridor Asset Management's 13F filing for Q1 2026, filed 12 May 2026.